Research to Prevent Blindness

Glaucoma may affect patients’ travel habits and health

For more on the impact of vision loss, read RPB's recent newsletter. RPB-supported research shows that patients with visual field loss from glaucoma travel less than those with normal vision,curtail...

Read More


Glaucoma Medication Delivered By Contact Lens

drug dispensing contact lens

RPB-supported researchers have demonstrated that a new type of contact lens can deliver a therapeutic amount of a glaucoma drug every day for a month.  The breakthrough, which has been pursued for decades, may...

Read More


Older Adults Experience More Vision Difficulties at Home

Elderly Man At Window

Adults have better vision in clinics rather than at home, due to poor home lighting, according to an RPB-supported study by Anjali M. Bhorade, M.D., MSCI, of the Washington University School of Medicine, St. Louis,...

Read More


Simple Urine Test Could Diagnose Retinitis Pigmentosa

composite of human retina

Research led by RPB-supported physician-scientists has produced a breakthrough discovery in diagnosing a blinding disease that affects about 1 in 4,000 people in the United States.Read the full story.

Read More


A Promising New Treatment for Macular Degeneration

RPB-supported researchers have published new findings indicating they are on the verge of developing a better treatment than the anti-VEGF injections currently used for macular degeneration. In studies, a class of...

Read More


RPB Awards Lab Grant to University of Florida

Research to Prevent Blindness (RPB) has awarded a prestigious, one-time laboratory grant of $600,000 to the Department of Ophthalmology at the University of Florida, College of Medicine.  The newly created...

Read More


RPB Researcher Pursues Clues to Rare Eye Disease that Could Help Millions

Screenshot from the video "A Blind Man's Journey"
Watch The Video

RPB Career Development Awardee Vinit Mahajan, MD, PhD is studying members of an Iowa family who are facing varying stages of blindness related to a rare genetic disorder known as autosomal dominant neovascular...

Read More


Researchers Discover New Relationship Between Rods and Cones

Rods and cones, the major light receptor cells in the mammalian eye, are densely packed across the retina where they convert light into the image-forming signals that allow the brain to create vision.  Rods...

Read More


RPB and OCT Research

OCT image of fovea

In addition to Dr. Wang’s work, RPB has funded many important OCT-related research projects since 2004:  Correlation of specific gene mutation in Stargardt’s disease with OCT-identified...

Read More


RPB Funding Yields Big Gains

Blood flow in the macula

Crowds at the ARVO 2013 meeting of nearly 12,000 vision scientists and physicians from around the world heard and saw the hundreds of ways that funding from Research to Prevent Blindness (RPB) is yielding major...

Read More


Bionic Retina Soon Available In the U.S.

Screenshot of video about the Arugus II Retinal Prosthesis System
Watch The Video

The first implantable device to treat advanced retinitis pigmentosa, the Argus II Retinal Prosthesis System, will be available at several clinical centers across the U.S. later this year. The system took more...

Read More


Coming Soon, A Blood Test to Predict When Dry AMD Becomes Wet?

Dr. Chavala AMD blood test.jpg

RPB-supported researchers have published a study that is the foundation for a promising new blood test to detect the earliest progression of macular degeneration to its more serious form, creating an opportunity for...

Read More


Research to Prevent Blindness, Inc. Names Brian Hofland as President

Brian F. Hofland

New York, NY, January 7, 2013 --Research to Prevent Blindness, Inc. (RPB) today named Brian F.  Hofland, Ph.D. as the sixth president in its 52-year history.  RPB is the leading nonprofit source of...

Read More



Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.